Two new class-action suits claim consumers aren’t reaping all of the benefits from the low prices dragging on the generic industry’s top players. Pharmacies and pharmacy benefit managers (PBMs) are winning instead, they say.
Healthcare Provider, Professor
Two new class-action suits claim consumers aren’t reaping all of the benefits from the low prices dragging on the generic industry’s top players. Pharmacies and pharmacy benefit managers (PBMs) are winning instead, they say.